Stem cells translational medicine

Brain Stem Cells Producing Growth Factor I as a New Treatment for Alzheimer's Disease

Updated

Abstract

The novel human cortex-derived neural stem cell line HK532-IGF-I shows enhanced neuroprotective capacity and long-term survival in a murine Alzheimer's disease model.

  • HK532-IGF-I cells produce increased levels of vascular endothelial growth factor.
  • These cells preferentially differentiate into gamma-aminobutyric acid-ergic neurons, which are dysregulated in Alzheimer's disease.
  • Autocrine production of insulin-like growth factor-I does not affect normal cellular functions such as proliferation and migration.
  • The enhanced neural stem cell line demonstrates long-term persistence in targeted brain areas after transplantation.

Simplified

Full Text

We can’t show the full text here under this license.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free